Gene Biotherapeutics, Inc. Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31)
Gene Biotherapeutics, Inc. reported Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31) of $599.21 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Income Statement › Other Income
us-gaap:SegmentReportingInformationRevenue · last filed 2013-05-15
- Gene Biotherapeutics, Inc. segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $599.21K, a 2826.09% increase year-over-year.
- Gene Biotherapeutics, Inc. segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $20.48K.
- Gene Biotherapeutics, Inc. segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for fiscal 2012 was $785.32K.
- Gene Biotherapeutics, Inc. segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for fiscal 2011 was $0.00.
| Period end | Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31) 3 month | Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31) 12 month |
|---|---|---|
| 2013-03-31 | $599.21K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $785.32K 10-K · filed 2013-04-05 | |
| 2012-03-31 | $20.48K 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $0.00 10-K · filed 2013-04-05 |